rxstat › Prices in Nova Scotia › Adalimumab
Adalimumab (Humira) price and coverage in Nova Scotia
Adalimumab 40 mg/0.8ml solution lists at $471.27 per billed unit in Nova Scotia on Nova Scotia Pharmacare's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Adalimumab is covered by Nova Scotia Pharmacare only under exception status: your prescriber has to request coverage, and it applies to patients who meet set criteria.
Price by strength in Nova Scotia
| Strength and form | Lowest price | Brand |
|---|---|---|
| 40 mg/0.8ml Solution9 products · special approval | $471.27/unit | – |
| 40 mg/0.4ml Solution8 products · special approval | $471.27/unit | – |
| 80 mg/0.8ml Solution5 products · special approval | $942.54/unit | – |
| 20 mg/0.4ml Solution3 products · special approval | $235.63/unit | – |
| 50 mg/ml Solution3 products · special approval | $235.64/unit | – |
| 20 mg/0.2ml Solution2 products · special approval | $235.63/unit | – |
All 30 products listed in Nova Scotia
| Product | Price | Coverage |
|---|---|---|
| 40 mg/0.8ml Solution | ||
| HadlimaORG · DIN 02473097 | $471.27/unit | Special approval |
| Hadlima PushtouchORG · DIN 02473100 | $471.27/unit | Special approval |
| HyrimozSDZ · DIN 02492164 | $471.27/unit | Special approval |
| HulioBIL · DIN 02502399 | $471.27/unit | Special approval |
| HulioBIL · DIN 02502402 | $471.27/unit | Special approval |
| IdacioFKB · DIN 02502674 | $471.27/unit | Special approval |
| AbriladaPFI · DIN 02511045 | $471.27/unit | Special approval |
| AbriladaPFI · DIN 02511053 | $471.27/unit | Special approval |
| HumiraABV · DIN 02258595 | – | Not covered |
| 40 mg/0.4ml Solution | ||
| YuflymaCLT · DIN 02523760 | $471.27/unit | Special approval |
| YuflymaCLT · DIN 02523779 | $471.27/unit | Special approval |
| SimlandiJPC · DIN 02523949 | $471.27/unit | Special approval |
| SimlandiJPC · DIN 02523957 | $471.27/unit | Special approval |
| HadlimaORG · DIN 02533472 | $471.27/unit | Special approval |
| Hadlima PushtouchORG · DIN 02533480 | $471.27/unit | Special approval |
| HyrimozSDZ · DIN 02542323 | $471.27/unit | Special approval |
| HyrimozSDZ · DIN 02542331 | $471.27/unit | Special approval |
| 80 mg/0.8ml Solution | ||
| SimlandiJPC · DIN 02523965 | $942.54/unit | Special approval |
| YuflymaCLT · DIN 02535076 | $942.54/unit | Special approval |
| YuflymaCLT · DIN 02535084 | $942.54/unit | Special approval |
| HyrimozSDZ · DIN 02542358 | $942.54/unit | Special approval |
| HyrimozSDZ · DIN 02542366 | $942.54/unit | Special approval |
| 20 mg/0.4ml Solution | ||
| AbriladaPFI · DIN 02511061 | $235.63/unit | Special approval |
| HulioBIL · DIN 02502380 | $235.63/unit | Special approval |
| HyrimozSDZ · DIN 02505258 | – | Not covered |
| 50 mg/ml Solution | ||
| AmgevitaAGA · DIN 02459310 | $235.64/unit | Special approval |
| AmgevitaAGA · DIN 02459299 | $471.27/unit | Special approval |
| AmgevitaAGA · DIN 02459302 | $471.27/unit | Special approval |
| 20 mg/0.2ml Solution | ||
| HyrimozSDZ · DIN 02542315 | $235.63/unit | Special approval |
| HumiraABV · DIN 02474263 | – | Not covered |
What you'll pay at the pharmacy
These are the prices Nova Scotia Pharmacare lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.
Shortage status
Partial shortage Supply is affected in Canada: see shortage status.
Adalimumab price in other provinces
Common questions
How much does Adalimumab cost in Nova Scotia?
Adalimumab 40 mg/0.8ml solution lists at $471.27 per billed unit in Nova Scotia on Nova Scotia Pharmacare's price list (Nov 1, 2026), before the pharmacy's dispensing fee.
Is Adalimumab covered in Nova Scotia?
Adalimumab is covered by Nova Scotia Pharmacare only under exception status: your prescriber has to request coverage, and it applies to patients who meet set criteria.
Is Adalimumab cheaper in another province?
For 40 mg/0.8ml solution, listed prices run from $471.27 to $471.27 across 4 provinces. Public plans only cover their own residents, though.
Source: Nova Scotia Pharmacare Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.